28 related articles for article (PubMed ID: 38670775)
1. Relation between intracellular location and photodynamic efficacy of 5-aminolevulinic acid-induced protoporphyrin IX in vitro. Comparison between human glioblastoma cells and other cancer cell lines.
Sailer R; Strauss WS; Wagner M; Emmert H; Schneckenburger H
Photochem Photobiol Sci; 2007 Feb; 6(2):145-51. PubMed ID: 17277837
[TBL] [Abstract][Full Text] [Related]
2. Peptide-targeted dendrimeric prodrugs of 5-aminolevulinic acid: A novel approach towards enhanced accumulation of protoporphyrin IX for photodynamic therapy.
Tewari KM; Dondi R; Yaghini E; Pourzand C; MacRobert AJ; Eggleston IM
Bioorg Chem; 2021 Apr; 109():104667. PubMed ID: 33611140
[TBL] [Abstract][Full Text] [Related]
3. Zwitterionic stealth peptide-capped 5-aminolevulinic acid prodrug nanoparticles for targeted photodynamic therapy.
Wu J; Lin Y; Li H; Jin Q; Ji J
J Colloid Interface Sci; 2017 Jan; 485():251-259. PubMed ID: 27676086
[TBL] [Abstract][Full Text] [Related]
4. In vitro comparison of hypericin and 5-aminolevulinic acid-derived protoporphyrin IX for photodynamic inactivation of medulloblastoma cells.
Ritz R; Scheidle C; Noell S; Roser F; Schenk M; Dietz K; Strauss WS
PLoS One; 2012; 7(12):e51974. PubMed ID: 23251668
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of aminolevulinic acid-mediated protoporphyrin IX fluorescence and enhancement by ABCG2 inhibitors in renal cell carcinoma cells.
Howley R; Mansi M; Shinde J; Restrepo J; Chen B
J Photochem Photobiol B; 2020 Oct; 211():112017. PubMed ID: 32919173
[TBL] [Abstract][Full Text] [Related]
6. A dew-responsive pectin-based herbicide for enhanced photodynamic inactivation.
Xu P; Liu J; Yi Y; Cai Z; Yin Y; Cai W; Zhang J; Gong Z; Xiao Y
Carbohydr Polym; 2024 Jul; 336():122114. PubMed ID: 38670775
[TBL] [Abstract][Full Text] [Related]
7. Targeting ABCG2 transporter to enhance 5-aminolevulinic acid for tumor visualization and photodynamic therapy.
Chandratre S; Olsen J; Howley R; Chen B
Biochem Pharmacol; 2023 Nov; 217():115851. PubMed ID: 37858868
[TBL] [Abstract][Full Text] [Related]
8. On the selectivity of 5-aminolevulinic acid-induced protoporphyrin IX formation.
Collaud S; Juzeniene A; Moan J; Lange N
Curr Med Chem Anticancer Agents; 2004 May; 4(3):301-16. PubMed ID: 15134506
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): mechanisms and clinical results.
Kennedy JC; Marcus SL; Pottier RH
J Clin Laser Med Surg; 1996 Oct; 14(5):289-304. PubMed ID: 9612195
[TBL] [Abstract][Full Text] [Related]
10. 5-Aminolevulinic Acid-Induced Protoporphyrin IX Fluorescence Imaging for Tumor Detection: Recent Advances and Challenges.
Harada Y; Murayama Y; Takamatsu T; Otsuji E; Tanaka H
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742921
[TBL] [Abstract][Full Text] [Related]
11. [5-Aminolevulinic acid (ALA) and its applications in neurosurgery].
Grieb P
Neurol Neurochir Pol; 2004; 38(3):201-7. PubMed ID: 15354233
[TBL] [Abstract][Full Text] [Related]
12. Rational design of 5-aminolevulinic acid derivatives aimed at improving photodynamic therapy.
Casas A; Batlle A
Curr Med Chem Anticancer Agents; 2002 Jul; 2(4):465-75. PubMed ID: 12678731
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
